[Clinical safety of liposomal amphotericin B]

Rev Iberoam Micol. 2021 Apr-Jun;38(2):56-60. doi: 10.1016/j.riam.2021.02.001. Epub 2021 May 12.
[Article in Spanish]

Abstract

This article reviews the safety profile of liposomal amphotericin B, emphasizing the renal toxicity; the risk factors for its presentation, incidence, severity, and potential reversibility are expounded.

Keywords: Adverse effects; Amphotericin B; Anfotericina B; Efectos adversos; Fracaso renal; Infusion related reactions; Kidney failure; Liver toxicity; Reacciones adversas relacionadas con la perfusión; Toxicidad hepática.

Publication types

  • Review

MeSH terms

  • Amphotericin B* / adverse effects
  • Antifungal Agents* / adverse effects
  • Incidence
  • Liposomes

Substances

  • Antifungal Agents
  • Liposomes
  • liposomal amphotericin B
  • Amphotericin B